| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO
1 company
Krishnan Ram is a CEO at Ernexa Therapeutics Inc.. Recent SEC Form 4 filings include 18 buys and 0 sells.
Estimated insider holdings value: $603K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2016 | ERNA Ernexa Therapeutics Inc. | CEO | Buy | 3,000 | $4.85 | $14,561.53 | +7.0% | |
| May 26, 2016 | ERNA Ernexa Therapeutics Inc. | CEO | Buy | 50,000 | $0.16 | $7,998.49 | +7.5% | |
| Mar 16, 2016 | ERNA Ernexa Therapeutics Inc. | CEO | Buy | 15,000 | $0.19 | $2,848.50 | +18.8% | |
| May 21, 2015 | ERNA Ernexa Therapeutics Inc. | CEO | Buy | 80,000 | $0.35 | $28,104.00 | New |